← Product Code [HRG](/submissions/OP/subpart-e%E2%80%94surgical-devices/HRG) · K981063 # AUTOMATED CORNEAL TREPHINE (K981063) _Laser Center Dev. Corp. · HRG · Jun 23, 1998 · Ophthalmic · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/OP/subpart-e%E2%80%94surgical-devices/HRG/K981063 ## Device Facts - **Applicant:** Laser Center Dev. Corp. - **Product Code:** [HRG](/submissions/OP/subpart-e%E2%80%94surgical-devices/HRG.md) - **Decision Date:** Jun 23, 1998 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 886.4070 - **Device Class:** Class 1 - **Review Panel:** Ophthalmic - **Attributes:** Therapeutic ## Intended Use The Automated Corneal Trephine is intended for preparation of recipient and donor comeas for lamellar and penetrating keratoplasty. ## Device Story Automated Corneal Trephine is a sterile, single-use, disposable device for corneal surgery. It features a DC motor that automatically rotates the trephine blade to create partial or full-thickness circular cuts for lamellar or penetrating keratoplasty. This automation replaces manual rotation used in traditional trephines. Blade depth is factory-preset to ensure precise penetration. Used by surgeons in clinical settings to prepare donor and recipient corneal tissue; improves consistency and precision of corneal incisions compared to manual methods. ## Clinical Evidence No clinical data provided; bench testing only. ## Technological Characteristics Materials: medical grade injection-molded plastic and stainless steel. Energy source: DC motor. Form factor: handheld, single-use, disposable trephine. Operation: automated rotation of cutting blade with factory-preset depth. ## Regulatory Identification A powered corneal burr is an AC-powered or battery-powered device that is a motor and drilling tool intended to remove rust rings from the cornea of the eye. ## Predicate Devices - Barron-Hessburg manual corneal trephine ([K864520](/device/K864520.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K981063 ## JUN 2 3 1998 510(k) Summary ## SUBMITTED: ## Submitted on behalf of: Company Name: Address: Phone: Fax: Laser Center Development Corporation 709 The Hamptons Lane Town & Country, MO 63017 314-514-1478 314-434-7030 CONTACT PERSON: Francis E. O'Donnell, Jr., M.D. ## OFFICIAL CORRESPONDENT: Firm Name: Address: : Phone: Fax: Francis E. O'Donnell, Jr., M.D. Laser Center Development Corporation 709 The Hamptons Lane Town & Country, MO 63017 314-514-1478 314-434-7030 DATE SUMMARY PREPARED: June 2, 1998 Automated Corneal Trephine COMMON NAME: TRADE NAME: Corneal Trephine SUBSTANTIALLY EQUIVALENT TO: The Automated Corneal Trephine, by I.aser Center Development Corporation, is substantially equivalent to the Barron-Hessburg manual corneal trephine (K864520). DESCRIPTION OF THE DEVICE: The Automated Corneal Trephine consists of a sterile, single use, disposable corneal trephine made of medical grade injection-molded plastic and stainless steel. The trephine is used to create a partial or full-thickness circular cut for lamellar or penetrating keratoplasty. This trephine features a DC motor which automatically rotates the trephine, eliminating cumbersome manual rotation. The blade depth is preset at the factory so that the extent of penetration is very precise. INDICATIONS FOR USE: The Automated Corneal Trephine is intended for preparation of recipient and donor comeas for lamellar and penetrating keratoplasty. {1}------------------------------------------------ Image /page/1/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States. The seal features the HHS logo, which consists of a stylized caduceus-like symbol with three figures intertwined. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged in a circular pattern around the logo. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 JUN 23 1998 Francis E. O'Donnell, Ir., M.D. President Laser Center Development Corporation 1028 South Kirkwood Road, Suite A St. Louis, MO 63122 Re: K981063 Trade Name: Automated Corneal Trephine Regulatory Class: I Product Code: 86 HRG Dated: June 2, 1998 Received: June 2, 1998 Dear Dr. O'Donnell: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations . {2}------------------------------------------------ Page 2 - Mr. Francis E. O'Donnell, Jr., M.D. This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, A. RoepL. Rosenthal A. Ralph Rosenthal, M.D. Director Division of Ophthalmic Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ - ......... Page 1 of 1 510(k) Number (if known): ___________________________________________________________________________________________________________________________________________________ Device Name: _________________________________________________________________________________________________________________________________________________________________ Indications For Usc: . - Lamellar keratoplasty - Penetrating Keratoplasty (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) | |
C. Callaway
(Division Sign-Off)
Division of Ophthalmic Devices
| | |----------------------|----------------------------------------------------------------------------------------------------------------------------------------------|--------------------------| | 510(k) Number | K981063 | | | Prescription Use |
OR
| Over-The-Counter Use | | (Per 21 CFR 801.109) | | (Optional Format 1-2-96) | --- **Source:** [https://fda.innolitics.com/submissions/OP/subpart-e%E2%80%94surgical-devices/HRG/K981063](https://fda.innolitics.com/submissions/OP/subpart-e%E2%80%94surgical-devices/HRG/K981063) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com